Ari Maizel

Chief Commercial Officer, Axsome Therapeutics.

Companies

Axsome TherapeuticsChief Commercial Officer Oct 24, 2024 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Axsome Therapeutics AXSM0 shares²Apr 22, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Apr 22, 2026Sold 7,500 shares at $182.42 of Axsome Therapeutics²
Apr 22, 2026Exercised options 7,500 shares at $70.73 of Axsome Therapeutics²
Jan 21, 2026Sold 7,500 shares at $184.44 of Axsome Therapeutics³
Jan 21, 2026Exercised options 7,500 shares at $70.73 of Axsome Therapeutics³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARAxsome Therapeutics, Chief Commercial Officer
2
SEC EDGARAxsome Therapeutics shares after the filing of Apr 22, 2026
3
SEC EDGARForm 4 filed Jan 23, 2026